These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19914076)

  • 1. Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship.
    Bonafoux DF; Bonar SL; Clare M; Donnelly AM; Glaenzer JL; Guzova JA; Huang H; Kishore NN; Koszyk FJ; Lennon PJ; Libby A; Mathialagan S; Oburn DS; Rouw SA; Sommers CD; Tripp CS; Vanella LJ; Weier R; Wolfson SG; Huang HC
    Bioorg Med Chem; 2010 Jan; 18(1):403-14. PubMed ID: 19914076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IkappaB kinase inhibitor.
    Tsuchiya A; Imai K; Asamitsu K; Waguri-Nagaya Y; Otsuka T; Okamoto T
    J Pharmacol Exp Ther; 2010 Apr; 333(1):236-43. PubMed ID: 20053934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,5-Disubstituted-indole-7-carboxamides: the discovery of a novel series of potent, selective inhibitors of IKK-β.
    Miller DD; Bamborough P; Christopher JA; Baldwin IR; Champigny AC; Cutler GJ; Kerns JK; Longstaff T; Mellor GW; Morey JV; Morse MA; Nie H; Rumsey WL; Taggart JJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2255-8. PubMed ID: 21429745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
    Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
    J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by a selective IkappaB kinase-2 inhibitor of interleukin-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture.
    Kondo Y; Fukuda K; Adachi T; Nishida T
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4850-7. PubMed ID: 18676628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation.
    Joo K; Lee Y; Choi D; Han J; Hong S; Kim YM; Jung Y
    Eur J Pharmacol; 2009 Sep; 618(1-3):91-7. PubMed ID: 19616541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
    Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
    J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
    Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
    Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
    Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A
    Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel derivatives of ISO-1 as potent inhibitors of MIF biological function.
    Balachandran S; Rodge A; Gadekar PK; Yadav VN; Kamath D; Chetrapal-Kunwar A; Bhatt P; Srinivasan S; Sharma S; Vishwakarma RA; Dagia NM
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4773-6. PubMed ID: 19592246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
    Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
    Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the suppressive actions of glucosamine on the interleukin-1beta-mediated activation of synoviocytes.
    Hua J; Sakamoto K; Kikukawa T; Abe C; Kurosawa H; Nagaoka I
    Inflamm Res; 2007 Oct; 56(10):432-8. PubMed ID: 18026701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IkappaB kinase-2-independent and -dependent inflammation in airway disease models: relevance of IKK-2 inhibition to the clinic.
    Birrell MA; Wong S; Hardaker EL; Catley MC; McCluskie K; Collins M; Haj-Yahia S; Belvisi MG
    Mol Pharmacol; 2006 Jun; 69(6):1791-800. PubMed ID: 16517756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression by Curcuma comosa Roxb. of pro-inflammatory cytokine secretion in phorbol-12-myristate-13-acetate stimulated human mononuclear cells.
    Sodsai A; Piyachaturawat P; Sophasan S; Suksamrarn A; Vongsakul M
    Int Immunopharmacol; 2007 Apr; 7(4):524-31. PubMed ID: 17321476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitors.
    Chen P; Norris D; Das J; Spergel SH; Wityak J; Leith L; Zhao R; Chen BC; Pitt S; Pang S; Shen DR; Zhang R; De Fex HF; Doweyko AM; McIntyre KW; Shuster DJ; Behnia K; Schieven GL; Barrish JC
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6061-6. PubMed ID: 15546730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-β.
    Avila CM; Lopes AB; Gonçalves AS; da Silva LL; Romeiro NC; Miranda AL; Sant'Anna CM; Barreiro EJ; Fraga CA
    Eur J Med Chem; 2011 Apr; 46(4):1245-53. PubMed ID: 21334796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
    Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
    Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis.
    Dyckman AJ; Langevine CM; Quesnelle C; Kempson J; Guo J; Gill P; Spergel SH; Watterson SH; Li T; Nirschl DS; Gillooly KM; Pattoli MA; McIntyre KW; Chen L; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):383-6. PubMed ID: 21087862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First asymmetric synthesis of CJ-14877 and its enantiomer and their interleukin-1beta inhibitory activities.
    Aoyagi Y; Adachi Y; Akagi S; Ohno N; Takeya K
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1876-8. PubMed ID: 19272778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L.
    Raghav SK; Gupta B; Shrivastava A; Das HR
    Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.